About Sris Pharmaceuticals
Sris Pharmaceuticals was a Healthcare company based in Hyderabad (India) founded in 2010 by Rama Chari. Manufacturer of generic solid and liquid dosage forms. It operates on a Traditional Pharmaceuticals model. Its chief executive, as recorded, is Rama Chari. Its Indian entity Sris Synthesis Private Limited reported revenue of ₹1.38 Cr. The company is recorded as dissolved. Sris Pharmaceuticals offers products and services including Sris Pharmaceuticals Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.
Company details
Sris Pharmaceuticals, led by Rama Chari as Founder CEO, specializes in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic solid and liquid dosage forms. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
- Headquarters Hyderabad, India
- Founders Rama Chari
- SectorsHealthcare
- Website srispharma.co.in
- Legal Name Sris Synthesis Private Limited
- Date of Incorporation 26 Feb, 2018
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1.38 Cr
FY 2022 · +94% YoY
- Net Profit₹1.9 Lakh
FY 2022 · 1% margin
- EBITDA-₹2 Lakh
FY 2022 · -1% margin
Associated legal entities of Sris Pharmaceuticals
Sris Pharmaceuticals operates through Sris Synthesis Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sris Synthesis Private Limited CIN U24304TG2018PTC122543 | Active | 26 Feb 2018 | Hyderabad, Telangana | ₹1.4 Cr | 2 | View details |
Products & Services of Sris Pharmaceuticals
Sris Pharmaceuticals offers a comprehensive portfolio of products and services, including Sris Pharmaceuticals Platform.
Manufacturer of generic solid and liquid dosage forms
Board of directors of Sris Synthesis Private Limited (Sris Pharmaceuticals)
Sris Synthesis Private Limited is the primary company behind Sris Pharmaceuticals. The board of Sris Synthesis Private Limited currently have 2 directors; the longest-serving is Bezagam Padma Sri, appointed in 2018.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bezagam Padma Sri DIN 08075125 | Director | 26 Feb 2018 | 8 yrs 8 mo | Sris Synthesis Private Limited |
| Bezagam Rama Chari DIN 01890599 | Managing Director | 26 Feb 2018 | 8 yrs 8 mo | Sris Synthesis Private Limited |
People of Sris Pharmaceuticals
1 people are tracked at Sris Pharmaceuticals (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for Sris Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sris Pharmaceuticals
Figures of Sris Synthesis Private Limited, the primary company behind Sris Pharmaceuticals, for FY 2022. Revenue was ₹1.38 Cr (+94% year on year). Net profit was ₹1.9 Lakh (1% margin). EBITDA was -₹2 Lakh (-1% margin). Revenue has grown at a compounded annual rate of +14% over three years.
- ₹1.38 CrRevenue · FY 2022 · +94% YoY
- ₹1.9 LakhNet profit · 1% margin
- -₹2 LakhEBITDA · -1% margin
- ₹5 LakhPaid-up capital
- +14%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Sris Synthesis Private Limited are on its company page.
Detailed financial statements for Sris Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Sris Pharmaceuticals
Sris Pharmaceuticals was founded in 2010.
Sris Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Rama Chari is the CEO of Sris Pharmaceuticals, as recorded in our data. They have also founded this company.
The primary company behind Sris Pharmaceuticals, Sris Synthesis Private Limited, reported revenue of ₹1.38 Cr for FY 2022, up 94% year on year.
Sris Pharmaceuticals, led by Rama Chari as Founder CEO, specializes in providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic solid and liquid dosage forms. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
Sris Pharmaceuticals offers Sris Pharmaceuticals Platform.
Sris Pharmaceuticals operates through Sris Synthesis Private Limited.
The legal entities of Sris Pharmaceuticals currently have 2 directors, including Bezagam Padma Sri, Bezagam Rama Chari.